Management of Pancreatic Cancer and Cholangiocarcinoma (2021)

個数:
  • ポイントキャンペーン

Management of Pancreatic Cancer and Cholangiocarcinoma (2021)

  • ウェブストア価格 ¥37,098(本体¥33,726)
  • Springer Verlag, Singapore(2021/07発売)
  • 外貨定価 US$ 169.99
  • 【ウェブストア限定】ブラックフライデーポイント5倍対象商品(~11/24)※店舗受取は対象外
  • ポイント 1,685pt
  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 324 p.
  • 言語 ENG
  • 商品コード 9789811628696
  • DDC分類 616.99436

Full Description

This comprehensive book presents the latest evidence-based data on pancreatobiliary malignancies, including the epidemiology, examination, treatment and endoscopic management. It explores a range of topics, such as risk factors, detection strategies, and novel treatment approaches like precision medicine and immunotherapy.

Although there have been rapid improvements in the management of these diseases, the survival period has not yet reached a satisfactory level. This book will help those doctors needing to share the latest information with the patients and their families. It provides a wealth of practical information to help surgeons, endoscopists and oncologists as well as physicians, basic researchers and professionals at medical device and pharmaceutical companies broaden their understanding of the current treatment and management strategies for pancreatobiliary malignancies.

Contents

Part I Current topics in epidemiology and examinations of Pancreas Cancer and Cholangiocarcinoma.- 1.Risk Factors for Pancreatic Cancer and Cholangiocarcinoma.-2. Detection strategies and examination of early pancreatic cancer.-.3. Biomarkers for Pancreatic Cancer and Cholangiocarcinoma -4. Recent advances of precision medicine in pancreatic cancer and and cholangiocarcinoma.- Part II Anti-cancer treatments for pancreas cancer.- 5.Chemotherapy for locally advanced and metastatic pancreatic cancer.- 6.Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer.-7. Adjuvant Chemotherapy for Pancreatic Cancer.-  8.Conversion Surgery in Pancreatic Cancer.- 9.Radiotherapy for pancreatic cancer.- Part III Anti-cancer treatments for cholangiocarcinoma.- 10.Chemotherapy for unresectable cholangiocarcinoma.- 11.Adjuvant chemotherapy for cholangiocarcinoma.- 12.Neoadjuvant therapy and conversion surgery for cholangiocarcinoma.- 13.Radiotherapyfor cholangiocarcinoma.- Part VI New Treatment for Pancreatic Cancer and Cholangiocarcinoma.- 14.Precision medicine for pancreatic cancer and cholangiocarcinoma.- 15. Immunotherapy for pancreatic cancer and biliary tract cancer.- 16. Treatment approach for pancreatic ductal adenocarcinoma with peritoneal dissemination.- 17.Treatment strategies for frail and elderly patients with pancreatic cancer.-Part V Endoscopic management of pancreas cancer and cholangiocarcinoma.- 18.Endoscopic diagnosis of pancreatic cancer and cholangiocarcinoma.- 19. Preoperative biliary drainage for pancreatic cancer and cholangiocarcinoma.- 20.ERCP for malignant biliary obstruction for unresectable pancreatic cancer and cholangiocarcinoma.- 21. Interventional EUS for pancreatic cancer and cholangiocarcinoma.- 22.Novel endoscopic focal therapy for pancreatic cancer and cholangiocarcinoma.- 23.Endoscopic management of gastrointestinal obstruction from pancreaticobiliary cancer.- 24. Development of Self-expandable Biliary Metal Stents for Pancreatic Cancer and Cholangiocarcinoma.

最近チェックした商品